<?xml version="1.0" encoding="UTF-8"?>
<ref id="B46">
 <label>46</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gille</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Dâ€™Andrea</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Tortorici</surname>
    <given-names>M. A.</given-names>
   </name>
   <name>
    <surname>Hartel</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Wright</surname>
    <given-names>S. D.</given-names>
   </name>
  </person-group>
  <article-title>CSL112 (apolipoprotein A-I [human]) enhances cholesterol efflux similarly in healthy individuals and stable atherosclerotic disease patients</article-title>
  <source>
   <italic toggle="yes">Arteriosclerosis, Thrombosis, and Vascular Biology</italic>
  </source>
  <year>2018</year>
  <volume>38</volume>
  <issue>4</issue>
  <fpage>953</fpage>
  <lpage>963</lpage>
  <pub-id pub-id-type="doi">10.1161/atvbaha.118.310538</pub-id>
  <pub-id pub-id-type="other">2-s2.0-85044397571</pub-id>
 </element-citation>
</ref>
